Actos Fast Facts
What You Need to know about Bladder Cancer
Actos has been Linked to Bladder Cancer and Other Health Risks
If you have been using Actos to control your type 2 diabetes and have now developed bladder cancer, there is a high likelihood that this cancer is related to your Actos presctiption. Actos is often times prescribed under its generic name, pioglitazone. Despite the consequences of taking Actos, the drug has been prescribed to
What is Actos?
Actos is owned and marketed by Takeda Pharmaceuticals. Takeda raked in $2.4 billion on the drug in 2008, which was the number ten seller worldwide.
FDA Warns of Actos-bladder Cancer Link
Preliminary results from a 10-year American study ending later in 2012 found long-term Actos users had 40 percent more instances of bladder cancer than people who never took the drug. Consequently, on June 15, 2011, the Food and Drug Administration issued a formal warning that patients taking Actos-containing medicines for more than 12 are at an increased risk for developing bladder cancer.
The FDA required new risk warnings on product inserts for:
- Actos (pioglitazone)
- Actoplus Met (pioglitazone/metformin)
- Actoplus Met XR (pioglitazone/metformin extended release)
- Duetact (pioglitazone/glimepride)
Source: FDA Drug Saftey Communications.
If you have Taken Actos, you should consult your doctor and an experienced attorney
There can be compensation available for your loss of health and for your medical bills and costs associated with treatment. There is currently a collection of of over 1000 Actos cases in Cook County in Illinois. Accordingly, an experienced attorney familiar with the procedures of the Illinois courts could investigate potential claims. Ryan R. Bradley, of Phebus & Koester, LLPis reviewing Actos cases for individuals across Illinois.